FLT3LG and neoplasm: ,43 However, the data from Clappaert et al.41warrant a thorough investigation of the DC subsets and the subsequent anti-tumor immune responses induced by FLT3L in cancer patients in order to clarify the utility of FLT3L treatment as a component of cancer therapies.